Results 171 to 180 of about 13,106 (183)

Concise Drug Review: Azacitidine and Decitabine

Oncologist, 2013
Jan Schellens, Jos Beijnen
exaly  

Low‐dose azacitidine after allogeneic stem cell transplantation for acute leukemia

Cancer, 2009
Guillermo Garcia-Manero, Richard Champlin, Elias Jabbour   +2 more
exaly  

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

International Journal of Molecular Sciences, 2017
Sonja Burgstaller, Lisa Pleyer, Richard Greil   +2 more
exaly  

Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia

Leukemia Research, 2016
Pierre Fenaux, Jean Emmanuel Kahn, Sophie Park   +2 more
exaly  

5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation, 2009
William Janssen, Anasetti C, List A
exaly  

Azacitidine

2013
openaire   +1 more source

Treatment of acute myelogenous leukemia with outpatient azacitidine

Cancer, 2006
John Lister
exaly  

Bioavailability of Azacitidine Subcutaneous Versus Intravenous in Patients With the Myelodysplastic Syndromes

Journal of Clinical Pharmacology, 2005
exaly  

Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes

British Journal of Haematology, 2013
Yoo Hong Min, Sung-Soo Yoon
exaly  

Azacitidine for the treatment of lower risk myelodysplastic syndromes

Cancer, 2010
Luca Maurillo, Adriano Venditti, Valeria Santini   +2 more
exaly